RxDoctor Payments Data

Susan George, MD

Internal Medicine · Worcester, MANPI 1609850759

Payments from drug & device makers

$13,935in general payments, 2019–2025

Across 534 payments — averaging $26.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Deciphera Pharmaceuticals Inc.$2K
  • AstraZeneca$1K
  • Lilly USA, LLC$995
  • Johnson & Johnson$989
  • AbbVie$983
  • Novartis$746
  • plus $7K from 54 others

What the payments were for

  • Speaking & faculty fees$2,20016%
  • Food & beverage$11,73384%
  • Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Deciphera Pharmaceuticals Inc.1$2,200
AstraZeneca55$1,153
Lilly USA, LLC40$995
Johnson & Johnson(2 entities)36$989
AbbVie(2 entities)41$983
Novartis37$746
Pfizer34$665
Boehringer Ingelheim22$521
Alnylam Pharmaceuticals Inc.21$508
GSK24$451
Merck19$354
Novo Nordisk16$349
Amgen14$290
E.r. Squibb & Sons, L.L.C.13$276
Inspire Medical Systems, Inc.18$257
Astellas Pharma US Inc10$231
Viiv Healthcare Company10$226
Abiomed7$212
Kiniksa Pharmaceuticals International, PLC8$204
Bayer10$200
Exact Sciences7$172
Aimmune Therapeutics, Inc.7$167
Biohaven Pharmaceutical Holding Company Ltd.6$126
Takeda Pharmaceuticals U.S.A., Inc.6$119
Gilead5$104
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$91
Daiichi Sankyo Inc.4$83
Vertex3$77
Madrigal Pharmaceuticals3$76
Insmed, Inc.4$75
Esperion Therapeutics, Inc.4$72
Braintree Laboratories, Inc.3$68
Teva Pharmaceuticals USA, Inc.4$67
Kiniksa Pharmaceuticals, Ltd.3$59
Amarin Pharma, Inc.3$57
Sumitomo Pharma America, Inc.2$55
Otsuka America Pharmaceutical, Inc.2$54
Abbott2$45
Eisai Inc.2$43
Ardelyx, Inc.2$41
Actelion Pharmaceuticals US, Inc.1$38
Invivyd Inc1$35
Agios Pharmaceuticals, Inc.1$30
Theratechnologies Inc.1$30
Sanofi Pasteur Inc.2$28
Baxter Healthcare1$28
Scpharmaceuticals Inc.1$26
Dexcom, Inc.1$26
Redhill Biopharma Inc.1$25
Lexicon Pharmaceuticals, Inc.1$25
Antares Pharma, Inc.1$23
Valinor Pharma, LLC1$20
Regeneron Healthcare Solutions, Inc.1$20
Seqirus USA Inc1$18
Phathom Pharmaceuticals, Inc.1$17
Ferring Pharmaceuticals Inc.1$17
Collegium Pharmaceutical, Inc.1$16
Kowa Pharmaceuticals America, Inc.1$16
Biodelivery Sciences International, Inc.1$14
Xeris Pharmaceuticals, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,935 in reported general payments places this provider in the 90th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$90,915
Medicare patients
240
Services billed
790

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl40$62,947
EliquisApixaban41$41,546
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$28,026
JardianceEmpagliflozin20$25,164
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr33$19,511
Breo ElliptaFluticasone/Vilanterol40$18,776
WegovySemaglutide11$14,399
SymbicortBudesonide/Formoterol Fumarate39$9,393
Atorvastatin Calcium456$7,760
Arnuity ElliptaFluticasone Furoate28$7,370
TrulancePlecanatide12$6,941
Rosuvastatin Calcium166$6,584
PremarinEstrogens, Conjugated16$5,959
Pregabalin50$5,519
Omeprazole266$4,937

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta$451$73,682134 claims
PfizerEliquis, Premarin$665$47,50557 claims
Boehringer IngelheimJardiance$521$25,16420 claims
Novo NordiskWegovy$349$14,39911 claims
AstraZenecaSymbicort$1,153$9,39339 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$91$6,94112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,983 internal medicine providers in Massachusetts.

Other internal medicine in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →